IN150 > (Ibandronate Sodium 150 mg (base))
Pill with imprint IN150 > is White, Capsule-shape and has been identified as Ibandronate Sodium 150 mg (base). It is supplied by Watson Laboratories, Inc..
Ibandronate is used in the treatment of prevention of osteoporosis; osteoporosis and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Ibandronate 150 mg (base) is not a controlled substance under the Controlled Substances Act (CSA).
Images for IN150 >
Ibandronate Sodium
- Imprint
- IN150 >
- Strength
- 150 mg (base)
- Color
- White
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Bisphosphonates
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Watson Laboratories, Inc.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00591-3770 | Watson Pharmaceuticals, Inc. |
| 42291-0336 | AvKare, Inc. |
Related Images for "IN150 >"
More about ibandronate
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 91 Reviews
- Drug class: bisphosphonates
- FDA Alerts (3)
Consumer resources
- Patient Information
- Ibandronate Intravenous (Advanced Reading)
- Ibandronate Oral, Injection (Advanced Reading)
- Ibandronate Tablets
- Ibandronate Injection
- Other brands
- Boniva
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.